IL17A and myeloid sarcoma: Another study, including 110 patients with MS, demonstrated that patients with insulin resistance (IR) had a higher level of disability (EDSS), higher levels of interleukin IL-6 and IL-17 and OS evaluated by tert-butyl hydroperoxide-initiated chemiluminescence and AOPPs compared to patients without IR.